Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Feb 22, 2020 in Colorectal cancer | 0 comments

In a nutshell

This study investigated the effectiveness of pelvic radiotherapy (PRT) followed by chemotherapy and surgery in advanced rectal cancer. Researchers suggested that this combined treatment is associated with improved survival rates.

Some background

Rectal cancer affects 44,180 people each year in the US. Up to 80% of these people present with inoperable liver metastasis (cancer spread to the liver) at diagnosis. Surgery to more than one tumor site is challenging. Therefore, the standard treatment used to be long-course chemotherapy and PRT. However, this has only a limited effect on distant metastasis.

Therefore, a new treatment program was introduced. It consisted of short-course PRT to the first tumor and chemotherapy to address the metastatic tumor. Patients who had tumor shrinkage can then receive surgery. The outcomes of patients with advanced rectal cancer receiving this treatment sequence are still unknown.

Methods & findings

This study included 169 patients with stage 4 rectal cancer and liver metastasis. These patients received short-course PRT followed by chemotherapy and surgery with or without other local therapies.

65.7% of these patients completed the treatment. The average follow-up was 49.5 months. Overall survival and progression-free survival (PFS; time from treatment to disease progression) were measured.

3-year PFS was 24.2% and 3-year overall survival was 48.8%. The average overall survival of patients who responded well and completed the treatment was 51.5 months. For patients who did not complete the treatment, the average overall survival was 15.1 months.  

Adequate management of the primary tumor symptoms was achieved in 87% of all patients.

The bottom line

This study concluded that short-course PRT followed by chemotherapy and tumor surgery is associated with improved survival rates in stage advanced rectal cancer.

The fine print

This study was based on medical records. Some information might have been missing.

Published By :

British Journal of Surgery

Date :

Feb 03, 2020

Original Title :

Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.

click here to get personalized updates